Company Description
Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia.
The company operates through Skin care, health and wellness; and Green energy segments. It offers two series of programs that consist of various services and products under the ATP Zeta Health Program and E.A.T.S.
names. The company also provides ionized and high bioavailability nutrients to enhance absorption at the cellular level, energized mineral concentrate, soy protein isolate powder, LIVO5, and solutions for sustainability and energy savings; and promotes environmental stewardship.
In addition, it promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies.
Further, the company provides renewable energy products, technical solutions, installations, and maintenance services.
Agape ATP Corporation was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.
| Country | Malaysia |
| Founded | 2016 |
| Industry | Packaged Foods |
| Sector | Consumer Staples |
| Employees | 16 |
| CEO | Kok Choong How |
Contact Details
Address: Lot 1705 – 1708, Faber Towers, Level 17, Tower 2 Kuala Lumpur, 58100 Malaysia | |
| Phone | 60 1 9223 0099 |
| Website | atpc.com.my |
Stock Details
| Ticker Symbol | ATPC |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001713210 |
| CUSIP Number | 008389108 |
| ISIN Number | US0083893067 |
| Employer ID | 36-4838886 |
| SIC Code | 8000 |
Key Executives
| Name | Position |
|---|---|
| Dr. Kok Choong How | Chairman of the Board, Founder, Group Chief Executive Officer, President, Chief Operating Officer, Treasurer and Secretary |
| Kam Fan Lee CPA | Chief Financial Officer |
| Dr. Wilfrendo Fernando Cortizo Ph.D. | Executive Director |
| Wan Lock Ting | Vice President of Corporate Finance |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 6, 2026 | S-3 | Registration statement under Securities Act of 1933 |
| Feb 6, 2026 | 8-K | Current Report |
| Feb 5, 2026 | 8-K | Current Report |
| Feb 2, 2026 | 8-K | Current Report |
| Jan 29, 2026 | 8-K | Current Report |
| Jan 28, 2026 | DEFR14A | Filing |
| Jan 9, 2026 | DEF 14A | Other definitive proxy statements |
| Dec 23, 2025 | PRER14A | Filing |
| Dec 12, 2025 | 8-K | Current Report |
| Dec 10, 2025 | PRE 14A | Other preliminary proxy statements |